The Small-Cap Powering the AI Revolution — But Can It Sustain the Surge?
Prepared for Our Today | Capital Markets & Investments Desk
KEY STATISTICS AT A GLANCE
| Exchange / Ticker | NASDAQ: AXTI |
| Sector | Semiconductors — Compound Substrate Materials |
| 52-Week Range | US$1.13 – US$47.03 |
| YTD Return (to Apr 10, 2026) | ~+292% |
| Market Capitalisation | Mid-cap (expanded post-rally) |
| FY2025 Revenue | US$88.3 million (-11% YoY) |
| FY2025 Net Loss | -US$21.4 million |
| Q4 2025 EPS | -US$0.08 (missed estimate of -US$0.06) |
| InP Backlog | Record >US$60 million |
| Analyst Consensus | Hold | Avg. Target: US$24.50 |
| Next Earnings Date | April 30, 2026 |
Executive Summary
AXT Inc. is one of the most extraordinary volatility stories of 2026. A semiconductor materials company headquartered in Fremont, California, with manufacturing operations in China, AXT has seen its stock price explode by nearly 300% year-to-date — from under US$10 at the start of the year to as high as US$64 — driven by a single, powerful investment thesis: the world’s AI infrastructure buildout cannot happen without the compound semiconductor wafers AXT manufactures.
The company controls approximately 40% of the global market for indium phosphide (InP) substrates — a specialised material that sits at the heart of high-speed optical connectivity inside AI data centres. Every major hyperscaler building out AI infrastructure needs these wafers. AXT has a record backlog exceeding US$60 million and has announced plans to more than double its InP production capacity by year-end 2026.
But the stock’s extraordinary run has also created a significant valuation puzzle. AXT is still posting losses. Its average analyst price target sits near US$24.50 — more than 60% below the stock’s recent trading price. Export permit volatility from China’s Ministry of Commerce caused Q4 2025 to badly miss targets, and a major industry stakeholder has publicly questioned the premise of an InP supply bottleneck that underpins the bullish case. This is not a simple story. It is a high-conviction, high-risk bet on a structural shift in semiconductor demand — and investors should understand it on both sides of the ledger.
Company Background: The Infrastructure Beneath the Infrastructure
Founded in 1986, AXT is not a household name — and that is precisely why the opportunity exists. The company designs and manufactures compound semiconductor wafer substrates: thin, highly engineered discs of crystalline material that serve as the physical foundation for advanced electronic components. While most investors are familiar with silicon — the backbone of conventional chips — compound semiconductors are a distinct class of materials engineered to perform where silicon cannot.
AXT’s core products are:
- Indium Phosphide (InP): Used in high-speed lasers, photodetectors and optical transceivers in data centre connectivity and fibre-optic networks.
- Gallium Arsenide (GaAs): Used in wireless power amplifiers, satellite communications, LED lighting and consumer electronics.
- Germanium (Ge): Used in satellite solar cells and fibre optics.
AXT operates a vertically integrated supply chain through partial ownership stakes in Chinese raw material ventures under its Tongmei subsidiary. This structure gives AXT a meaningful cost and speed advantage in scaling production — but it also creates the geopolitical exposure that has defined the stock’s volatility in 2025 and 2026. The company is also in the process of pursuing a listing of the Tongmei subsidiary on Shanghai’s STAR Market, which would unlock a separate valuation for that asset.
The AI Infrastructure Thesis: Why InP Matters
To understand AXT’s investment case, one must first understand the architecture of an AI data centre. The processing power behind large language models and generative AI systems requires not just GPUs and TPUs — it requires the ability to move vast amounts of data between chips at extraordinary speed. That data movement happens through optical interconnects: fibre-optic links operating at speeds that far exceed what copper wire can handle. Indium phosphide is the material that makes those optical interconnects possible.
As AI spending has accelerated across hyperscalers — Microsoft, Google, Amazon, Meta and others — demand for InP substrates has grown sharply. AXT, with a roughly 40% share of the global InP substrate market, sits at a critical chokepoint in this supply chain. The company reported a record backlog exceeding US$60 million for InP wafers in early 2026, and management has committed to more than doubling its InP manufacturing capacity in the second half of the year.
The broader semiconductor market context supports the narrative. Global semiconductor sales reached approximately US$791.7 billion in 2025, with projections for 8–9% growth in 2026 — growth driven heavily by AI infrastructure investment. AXT’s niche role in that supply chain has caused investors to reprice the stock aggressively, reflecting the possibility that InP substrates become a strategic bottleneck as AI data centre investment accelerates through the decade.
Financial Performance: Growth Story, Profitability Challenge
The financial picture at AXT is a study in contrast. The company’s top-line trajectory tells a story of a business in recovery — but the bottom line remains a work in progress.
REVENUE & PROFITABILITY SNAPSHOT
| FY2024 Revenue | US$99.4 million |
| FY2025 Revenue | US$88.3 million (-11% YoY) |
| Q4 2025 Revenue | US$23.0 million (below US$24.2M estimate) |
| FY2025 Net Loss | -US$21.4 million (+81.7% wider than 2024) |
| Gross Margin | ~24% |
| Net Margin | ~-12% |
| Free Cash Flow | Negative |
| Capital Raise (Dec 2025) | US$87 million public offering |
Revenue actually declined in FY2025 — not because demand was weak, but because China’s Ministry of Commerce added indium phosphide to its export control list in February 2025. This required AXT to obtain government permits for each overseas shipment of InP substrates. The permitting process proved unpredictable and timing-volatile, causing AXT to miss Q4 2025 guidance significantly. The company had originally guided to US$27–30 million in Q4 revenue, which it was forced to lower to US$22.5–23.5 million due to delayed permits in December.
In December 2025, AXT completed a US$87 million public equity offering — dilutive to existing shareholders, but strategically important. The proceeds are earmarked for capacity expansion, particularly for indium phosphide. Management cited improving permit approvals in early 2026 and guided for sequential revenue growth in Q1 2026. The next earnings release on April 30, 2026, will be the critical test of that recovery.
Stock Performance: A 2026 Phenomenon
The performance of AXTI shares in 2026 has been nothing short of extraordinary — and nothing short of volatile. The stock began 2026 near the bottom of its 52-week range, scarred by Q4 earnings disappointments and export permit uncertainty. What followed was a dramatic rerating driven by AI sentiment, improving operational signals, and intense retail investor participation.
On April 8, 2026, shares surged more than 19% in a single session, climbing to approximately US$54.10, on renewed optimism over its AI infrastructure role and pre-earnings positioning. As of April 10, 2026, the trailing one-year return on AXTI exceeded 292% against the S&P 500’s 0.42% over the same period. The 52-week trading range of US$1.13 to US$47.03 (with intraday prints above US$60) captures the full spectrum of this volatility.
However, the stock has also demonstrated sharp downside moves that serve as a reminder of the risks embedded in speculative momentum. On March 4, 2026, AXTI fell nearly 8% in a single session. A subsequent drop of approximately 20% was triggered in part by concerns over a large share authorisation and insider selling activity — signals that prompted B. Riley Securities to describe itself as “incrementally cautious” on the name.
The Bull Case: Structural Demand Meets Concentrated Supply
The bullish investment thesis for AXT rests on several structural pillars that, if they hold, would make the current price look reasonable in hindsight:
- Monopolistic market position: AXT controls approximately 40% of global InP substrate supply. In a market where demand is accelerating, dominant share is a powerful lever.
- Capacity doubling: Plans to more than double InP manufacturing capacity in H2 2026 position AXT to capture the surge in demand as the AI buildout accelerates.
- Record backlog: A backlog exceeding US$60 million provides revenue visibility — a critical asset when a company is in a transition from losses to profitability.
- Vertically integrated cost structure: The Tongmei subsidiary’s raw material ownership provides cost advantages that pure-play substrate competitors lack.
- Tier-1 customer acquisition: Management has indicated an expansion of its customer base to include significant Tier-1 technology firms — a signal of accelerating commercial momentum.
The Bear Case: Valuation, Volatility, and Geopolitical Risk
The bearish case for AXT is equally compelling, and any serious investor must engage with it directly:
RISK MATRIX
| Risk Factor | Description | Severity |
| Export Control Risk | China’s Ministry of Commerce controls InP permit timing. A permit slowdown directly caps AXT’s ability to ship product, as seen in Q4 2025. | High |
| Valuation Disconnect | AXTI recently traded ~90% above its average analyst price target of US$24.50. The stock prices in a significant revenue and margin recovery not yet reflected in results. | High |
| Persistent Losses | AXT has negative free cash flow and net margins of approximately -12%. Profitability depends on rapid revenue scale and utilisation improvement. | Medium |
| Demand Bottleneck Dispute | At least one major InP industry stakeholder has publicly challenged the notion that there is a genuine InP supply bottleneck — potentially undermining the core bull thesis. | Medium |
| Insider & Dilution Signals | Escalating tariffs and trade policies between the US and China create structural uncertainty around AXT’s entire operational model. | Medium |
| US-China Trade Tension | Escalating tariff and trade policies between the US and China create structural uncertainty around AXT’s entire operational model. | High |
What Analysts Are Saying
Sell-side sentiment on AXT remains cautious relative to the stock’s market performance. The average analyst price target stands at US$24.50, with a range of US$21.00 to US$45.00 — broadly reflecting a view that the stock has run significantly ahead of its near-term fundamentals. The consensus rating as of April 2026 is Hold.
B. Riley Securities, one of the more active analysts on the name, issued a Maintains rating in February 2026 following Q4 results, but subsequently flagged incremental caution in March following what it described as concerning signals in the supply chain. Wedbush has been more constructive, issuing a price target increase reflecting confidence in the AI demand thesis.
The divergence in analyst views reflects the genuine uncertainty embedded in AXT’s story. The company’s potential is clear — but the pathway from that potential to delivered earnings requires the resolution of export permit unpredictability, a successful capacity doubling, and continued strength in AI infrastructure spending. Any one of these could disappoint.
Our Assessment: A High-Conviction Bet With Eyes Wide Open
AXT Inc. represents one of the most fascinating and difficult equity assessments in today’s market. It is a genuine structural growth story — a business positioned at a critical chokepoint in the AI infrastructure supply chain, with dominant market share, a record backlog, and capacity expansion underway. For long-term investors with high risk tolerance and genuine conviction in the permanence of AI-driven optical connectivity demand, the narrative is compelling.
But the stock’s extraordinary YTD performance has created a significant price-to-reality gap. Trading at multiples that price in substantial forward improvement while the company still generates losses and faces unresolved geopolitical supply chain risks, AXTI demands careful position-sizing and active risk management. This is not a name for passive, set-and-forget investors.
The April 30, 2026, earnings release will be the pivotal event. If AXT delivers the sequential Q1 revenue recovery management guided for — and demonstrates that export permits are flowing — the re-rating could be sustained. If Q1 disappoints again, the distance between price and analyst targets will compress painfully and quickly.
| “AXT sits at a genuine intersection of compound semiconductor science and AI infrastructure demand. The question investors must answer is not whether the opportunity is real — it is whether the current price already reflects it.” |
DISCLAIMER
This article is produced for informational and educational purposes only and does not constitute financial, investment, or legal advice. The analysis reflects publicly available information as of April 13, 2026. Our Today and its contributors do not hold positions in the securities mentioned. Readers are encouraged to consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.
Comments